Hr-positive Advanced Breast Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2023-04-06
Clinical Trial Update: Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating iribrine plus tucidinostat in HR+/HER2- advanced breast cancer after CDK4/6 inhibitor failure is liste…